ATE293974T1 - Pharmazeutische zusammensetzungen zur unbehagenverminderung - Google Patents

Pharmazeutische zusammensetzungen zur unbehagenverminderung

Info

Publication number: ATE293974T1
Authority: AT; Austria
Prior art keywords: products; pharmaceutical compositions; infants; vitamin; discomfort reduction
Prior art date: 1999-01-20

Application number

AT00903030T

Other languages

English (en)

Inventor

Robert Johan Joseph Hageman

Jacob Geert Bindels

Original Assignee

Nutricia Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-01-20

Filing date

2000-01-20

Publication date

2005-05-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26153242&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE293974(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-01-20 Application filed by Nutricia Nv filed Critical Nutricia Nv

2005-05-15 Application granted granted Critical

2005-05-15 Publication of ATE293974T1 publication Critical patent/ATE293974T1/de

Links

239000008194 pharmaceutical composition Substances 0.000 title 1
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract 2
LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 2
QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 2
YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 abstract 1
OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract 1
229930003779 Vitamin B12 Natural products 0.000 abstract 1
150000001720 carbohydrates Chemical class 0.000 abstract 1
FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 1
230000006806 disease prevention Effects 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
229960000304 folic acid Drugs 0.000 abstract 1
235000019152 folic acid Nutrition 0.000 abstract 1
239000011724 folic acid Substances 0.000 abstract 1
DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 abstract 1
229960003987 melatonin Drugs 0.000 abstract 1
230000004060 metabolic process Effects 0.000 abstract 1
235000016709 nutrition Nutrition 0.000 abstract 1
230000035764 nutrition Effects 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 1
229940076279 serotonin Drugs 0.000 abstract 1
235000019163 vitamin B12 Nutrition 0.000 abstract 1
239000011715 vitamin B12 Substances 0.000 abstract 1
235000019158 vitamin B6 Nutrition 0.000 abstract 1
239000011726 vitamin B6 Substances 0.000 abstract 1
229940011671 vitamin b6 Drugs 0.000 abstract 1
230000036642 wellbeing Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/801—Pediatric

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Nutrition Science (AREA)
Mycology (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Inorganic Chemistry (AREA)
Pediatric Medicine (AREA)
Immunology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Obesity (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Anesthesiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

AT00903030T 1999-01-20 2000-01-20 Pharmazeutische zusammensetzungen zur unbehagenverminderung ATE293974T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP99200166		1999-01-20
EP99201359A EP0951842B1 (de)	1999-01-20	1999-04-29	Säuglingsnährpräparat
PCT/NL2000/000042 WO2000043013A1 (en)	1999-01-20	2000-01-20	Pharmaceutical compositions for alleviating discomfort

Publications (1)

Publication Number	Publication Date
ATE293974T1 true ATE293974T1 (de)	2005-05-15

Family

ID=26153242

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT99201359T ATE228779T1 (de)	1999-01-20	1999-04-29	Säuglingsnährpräparat
AT00903030T ATE293974T1 (de)	1999-01-20	2000-01-20	Pharmazeutische zusammensetzungen zur unbehagenverminderung

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AT99201359T ATE228779T1 (de)	1999-01-20	1999-04-29	Säuglingsnährpräparat

Country Status (11)

Country	Link
US (4)	US6900180B1 (de)
EP (2)	EP0951842B1 (de)
JP (2)	JP2002535277A (de)
AT (2)	ATE228779T1 (de)
AU (2)	AU2466500A (de)
CA (2)	CA2359592C (de)
DE (2)	DE69904257T2 (de)
DK (1)	DK0951842T3 (de)
ES (2)	ES2187115T3 (de)
PT (1)	PT951842E (de)
WO (2)	WO2000042868A1 (de)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0951842B1 (de) *	1999-01-20	2002-12-04	N.V. Nutricia	Säuglingsnährpräparat
GB9906740D0 (en)	1999-03-23	1999-05-19	Kilgowan Limited	Oral combinations of hydroxocobalamin and folic acid
AU771754B2 (en) *	1999-06-29	2004-04-01	New Zealand Milk Institute Limited, The	Prophylactic dietary supplement based on milk
US6627213B2 (en) *	1999-08-20	2003-09-30	Wisconsin Alumni Research Foundation	Inhibition of neonatal hyperbilirubinemia in breast fed infants
US7208180B2 (en)	2000-05-08	2007-04-24	N.V. Nutricia	Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith
CA2445512C (en)	2001-04-25	2010-10-12	Cobalz Limited	A method for treating or preventing a functional vitamin b12 deficiency in an individual and medical compositions for use in said method
US20100268658A1 (en) *	2001-05-14	2010-10-21	Prolacta Bioscience	Method for collecting, testing and distributing milk
US20030104033A1 (en) *	2001-07-13	2003-06-05	Lai Chon-Si	Enteral formulations
NL1019368C2 (nl) *	2001-11-14	2003-05-20	Nutricia Nv	Preparaat voor het verbeteren van receptorwerking.
US7651716B2 (en)	2001-12-21	2010-01-26	Wyeth Llc	Methods for reducing adverse effects of feeding formula to infants
JP4521168B2 (ja) *	2002-08-15	2010-08-11	テルモ株式会社	血糖値上昇抑制用のビタミンｂ１含有栄養組成物
US7951410B2 (en)	2003-04-14	2011-05-31	Mead Johnson Nutrition Company	Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
US20040214791A1 (en) *	2003-04-25	2004-10-28	Nancy Auestad	High lactose infant nutrition formula
JP4721631B2 (ja) *	2003-09-30	2011-07-13	小林製薬株式会社	催眠剤組成物
CA2556753C (en) *	2004-02-20	2014-11-25	Lifescape Biosciences Incorporated	Compositions and methods for sleep regulation
WO2005094849A1 (ja) *	2004-03-31	2005-10-13	Calpis Co., Ltd.	内因性メラトニン分泌リズム改善用機能性食品、及び概日リズム改善用機能性食品
WO2005110124A1 (en) *	2004-04-15	2005-11-24	Abbott Laboratories	Composition and methods for nutritional management of patients with hepatic disease
US20050272691A1 (en) *	2004-06-04	2005-12-08	Eaton Kevin P	Treatment of dermatological conditions
ATE361101T1 (de) *	2004-08-24	2007-05-15	Nutricia Nv	Nahrungszusammensetzung die unverdauliche oligosaccharide enthält
ES2259885B1 (es) *	2004-09-29	2007-11-01	Laboratorios Ordesa, S.L.	Kit nutricional infantil para regular el ciclo de sueño-vigilia.
DE102005001645A1 (de) *	2005-01-13	2006-07-20	Gerhard Dr. Sauermann	Topisches Produkt zur Vorbeugung und Behandlung von Windeldermatitis
EP1680967A1 (de) *	2005-01-14	2006-07-19	Forum Media Productions SPRL	Diätetische Zusammensetzungen auf Basis von löslichem Milchproteinisolat
DE102005012060A1 (de) *	2005-03-16	2006-09-21	Gerhard Dr. Sauermann	Orales Produkt zur Vorbeugung und Behandlung von Windeldermatitis
JP2006321742A (ja) *	2005-05-18	2006-11-30	Tokyo Medical & Dental Univ	睡眠改善薬
WO2007035870A2 (en)	2005-09-20	2007-03-29	Prolacta Bioscience, Inc.	A method for testing milk
GB2432772B (en) *	2005-11-30	2011-06-01	Sis	Improvements in and relating to nutritional products
DK1800675T3 (da)	2005-12-23	2011-09-05	Nutricia Nv	Sammensætninger omfattende polyumættede fedtsyrer, proteiner og mangan og/eller molybdæn og nucleosider/nucleotider til behandling af demens
EP1962617A2 (de) *	2005-12-23	2008-09-03	N.V. Nutricia	Babynahrungszusammensetzungen zur verhinderung von fettleibigkeit
MY163134A (en) *	2006-03-15	2017-08-15	Suntory Holdings Ltd	Composition containing riboflavin and sesamin-class compounds
PT1996031E (pt) *	2006-03-23	2009-12-16	Nutricia Nv	Fórmula para recém-nascido pré-termo
BRPI0601834A (pt) *	2006-03-30	2007-11-27	Ricardo De Souza Pereira	suplementação dietética para curar ou regredir sintomas de refluxo gastroesofágico, gastrite e úlceras
US20070299127A1 (en) *	2006-06-23	2007-12-27	The Procter & Gamble Company	Compositions and kits comprising a melatonin component and an omega-3-fatty acid component
US20080057144A1 (en) *	2006-09-01	2008-03-06	Cathy Beggan	Wake up on time dietary supplement and method of use
EP2099321B1 (de) *	2006-11-29	2017-04-19	Prolacta Bioscience, Inc.	Muttermilchzusammensetzungen sowie verfahren zu ihrer herstellung und verwendung
EP2101597B1 (de)	2006-12-08	2012-10-17	Prolacta Bioscience, Inc.	Zusammensetzungen menschlicher fette sowie verfahren zu ihrer herstellung und verwendung
EP1932437A1 (de) *	2006-12-15	2008-06-18	Nestec S.A.	Kinderformel
JP5591533B2 (ja)	2007-03-15	2014-09-17	サントリーホールディングス株式会社	抗疲労剤
WO2009091885A1 (en) *	2008-01-16	2009-07-23	Babak Baban	Health beverages comprising cinnamon extract and methods of making and using the same
US8536199B2 (en) *	2008-03-25	2013-09-17	Sarah Steinberg Greenwald	Oral combination of vitamins
WO2009132950A1 (en) *	2008-04-29	2009-11-05	Unilever Nv	Process for the preparation of packaged heat-preserved aqueous drink comprising casein micelles and tryptophan-rich peptides, and product so obtained
PL2282641T3 (pl) *	2008-04-29	2013-01-31	Dsm Ip Assets Bv	Kompozycja zawierająca węglowodany i peptydy, które zawierają tryptofan
US20090286750A1 (en) *	2008-05-16	2009-11-19	Kasubick Robert V	Use of ribose in lessening the clinical symptoms of aberrant firing of neurons
EA011075B1 (ru) *	2008-06-20	2008-12-30	Лев Михайлович МОГИЛЕВСКИЙ	Сухая молочная смесь
EP2349246A1 (de) *	2008-11-26	2011-08-03	Igor Anatolievich Pomytkin	Cholinsalze der bernsteinsäure zur behandlung von depression, angstzuständen, schizophrenie, schlafstörung und epilepsie
JP2012510476A (ja)	2008-12-02	2012-05-10	プロラクタバイオサイエンス，インコーポレイテッド	ヒト乳透過組成物ならびにその製造および使用方法
US9848760B2 (en) *	2009-06-29	2017-12-26	Gearbox, Llc	Devices for continual monitoring and introduction of gastrointestinal microbes
US7862838B1 (en) *	2009-08-31	2011-01-04	Qing Si Zeng	Composition and regimen for the treatment of herpes simplex and herpes zoster primarily by eliminating their pathogenetic conditions and taking into account both pathogenesis and etiology
CN102481277A (zh) *	2009-09-30	2012-05-30	株式会社资生堂	紫外线损伤减轻口服组合物
RU2500301C1 (ru) *	2009-12-18	2013-12-10	Стукли-Ван Кэмп, Инк.	Белковый восстанавливающий напиток
JP5094899B2 (ja) *	2010-03-23	2012-12-12	小林製薬株式会社	催眠剤組成物
EP2554058A4 (de)	2010-03-31	2013-12-25	Vegenat S A	Funktionelle nahrungsergänzung, im besonderen zur ernährung und prävention sowie verbesserung von neurologischen erkrankungen, neurodegenerativen erkrankungen oder kognitiven störungen
WO2011121150A1 (es)	2010-03-31	2011-10-06	Vegenat, S.A.	Producto alimenticio enteral u oral especialmente destinado para la nutrición, prevención y mejora de alteraciones neurológicas, neurodegenerativas o trastornos cognitivos
RU2594876C2 (ru) *	2010-12-07	2016-08-20	Нестек С.А.	Способы и композиции, предназначенные для улучшения сна у животных
PT2739157T (pt)	2011-08-03	2018-01-09	Prolacta Bioscience Inc	Microfiltração de leite humano para reduzir a contaminação bacteriana
EP2583562A1 (de) *	2011-10-21	2013-04-24	Nestec S.A.	Verwendung von Molkeproteinmizellen für Kinder mit Adipositas- oder Diabetesrisiko
WO2014007606A1 (en)	2012-07-05	2014-01-09	N.V. Nutricia	Product for use in the prophylactic or therapeutic treatment of a negative emotion or introvert behaviour
JP6368306B2 (ja) *	2012-07-31	2018-08-01	ネステクソシエテアノニム	炎症性腸疾患（ｉｂｄ）患者の筋骨格の健康を促進させるための栄養組成物
CA2902990C (en)	2013-03-13	2021-11-16	Prolacta Bioscience, Inc.	High fat human milk products
WO2015099102A1 (ja) *	2013-12-27	2015-07-02	富士フイルム株式会社	亜鉛含有睡眠改善剤、ノンレム睡眠時間増加剤及び鎮静剤
IL303044B2 (en)	2015-12-30	2025-05-01	Prolacta Bioscience Inc	Human milk products used before and after active treatment
US10617700B1 (en) *	2016-02-26	2020-04-14	Michelle Ann Toothman	Vitamin supplement compositions with enhanced bioavailability
US10039765B1 (en) *	2016-02-26	2018-08-07	Michelle Ann Toothman	Vitamin supplement compositions with enhanced bioavailability
US11122833B1 (en) *	2016-02-26	2021-09-21	Michelle Ann Toothman	Infant formulas having vitamin complexes with enhanced bioavailability
US10039805B1 (en) *	2016-02-26	2018-08-07	Michelle Ann Toothman	Infant formulas having vitamin complexes with enhanced bioavailability
EP3400935A1 (de) *	2017-05-12	2018-11-14	Hospital Sant Joan de Deu	Betain zur verhinderung von adipositas
CN107198078A (zh) *	2017-06-05	2017-09-26	天津市德恒科技有限公司	黄疸期小肽生长营养素及工艺制造方法
US11197917B2 (en)	2017-12-01	2021-12-14	ByHeart, Inc.	Formulations for nutritional support in subjects in need thereof
WO2020011629A1 (en) *	2018-07-07	2020-01-16	Ivica Cepanec	Composition of powderous instant drink, its preparation and use
AU2019363061A1 (en) *	2018-10-17	2021-04-29	Frieslandcampina Nederland B.V.	Sleep-improving compositions
TW202126317A (zh)	2019-09-24	2021-07-16	美商普拉塔生技公司	用於治療發炎和免疫疾病之組成物和方法
RU2709500C1 (ru) *	2019-10-15	2019-12-18	Виктор Александрович Сисев	Фармацевтическая композиция для парентерального капельного введения
CA3212435A1 (en) *	2021-03-15	2022-09-22	Lara Nyman	Nutritional composition for improving sleep
WO2025233731A1 (en) *	2024-05-10	2025-11-13	A. Menarini International Licensing S.A.	Nutritional composition comprising vitamin b6, vitamin b9 and vitamin d for the treatment of sleep disorders

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3390039A (en) *	1964-10-09	1968-06-25	Eastman Kodak Co	Method and apparatus for making additive filters
US3415655A (en) *	1965-10-19	1968-12-10	Ajinomoto Kk	Milk product containing free amino acids and method of preparing the same
US3930039A (en) *	1971-07-30	1975-12-30	Molkerei J A Meggle Milchindus	Method of preparing a protein concentrate from whey
US4210637A (en) *	1978-07-31	1980-07-01	Massachusetts Institute Of Technology	Composition and method for suppressing appetite for calories as carbohydrates
US4491589A (en) *	1982-05-17	1985-01-01	The Trustees Of Columbia University In The City Of New York	Amino acid solutions for parenteral nutrition and methods of formulation and use
NZ208538A (en)	1983-06-16	1987-08-31	Farley Health Products	Liquid infant food containing vitamin b 2
IT1212792B (it)	1983-11-30	1989-11-30	Egidio Aldo Moja	Supplemento dietetico e alimento preconfezionato che lo contiene procedimento di preparazione e metodo di somministrazione
GB8523338D0 (en) *	1985-09-20	1985-10-23	Kreitzman S N	Treatment of obesity
US4920098A (en) *	1986-09-17	1990-04-24	Baxter International Inc.	Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
GB8900924D0 (en) *	1989-01-17	1989-03-08	Amco Chemie Handel	Compositions for use in enzyme deficiencies
US5631271A (en) *	1986-11-29	1997-05-20	Serfontein; Willem J.	Methods and preparations for the treatment and prophylaxis of metabolic disturbances
US5053429A (en)	1988-04-08	1991-10-01	The Lithox Corporation, Inc.	Treating inflammatory pain with methionine
FI892006L (fi)	1988-04-29	1989-10-30	Phil Gold	Lactalbumin saosom tillaeggsaemne i mat.
US5075290A (en)	1989-06-28	1991-12-24	University Of Virginia Alumni Patents Foundation	Use of adenosine, adenosine analogs or nucleoside uptake blockers, e.g. dipyridamole, as drug treatments for obstructive sleep apnea and snoring
FR2657013B1 (fr)	1990-01-18	1992-05-15	Medgenix Group Sa	Composition dietetique a base de polypeptides et acides amines.
US5132113A (en) *	1990-10-26	1992-07-21	Maurizio Luca	Nutritional composition containing essential amino acids
IT1247125B (it) *	1991-03-01	1994-12-12	Depha Team Srl	Composizioni dietetiche o farmaceutiche per il ripristino del contenuto cellulare degli adenin nucleotidi nel muscolo scheletrico e cardiaco.
ES2134789T3 (es) *	1991-05-09	1999-10-16	Neurim Pharma 1991	Composiciones que contienen melatonina.
DE4130284A1 (de) *	1991-09-12	1993-03-18	Willi Prof Dr Med Habil Heine	Verfahren zur herstellung biologisch hochwertiger nahrungseiweisse
CA2078019C (en) *	1991-09-13	2002-08-27	Siegbert Heinrich Bissbort	Substance or composition and uses thereof
US5292538A (en) *	1992-07-22	1994-03-08	Metagenics, Inc.	Improved sustained energy and anabolic composition and method of making
CN1087522A (zh) *	1992-09-14	1994-06-08	韦斯塔药品有限公司	用于治疗和预防婴儿代谢紊乱的组合物
DE4326675C2 (de) *	1993-08-09	1996-12-12	Puetter Medice Chem Pharm	Verwendung einer Kombination aus Folsäure, Vitamin B¶6¶ und Vitamin B¶1¶¶2¶ zur Vorbeugung von Nervendegenerationserkrankungen und Altersdementia
US5700590A (en) *	1994-01-10	1997-12-23	Abbott Laboratories	Nutritional formula with ribo-nucleotides
US5691325A (en)	1994-01-14	1997-11-25	Sandyk; Reuven	Method for ameliorating age-related disease conditions
US20070231402A1 (en) *	1994-08-02	2007-10-04	Immunopath Profile, Inc.	Therapeutic stem cell composition and stimulant, facilitator, accelerator, and synergizer thereof, growth factor, anti-inflammatory composition and uses thereof
US5549905A (en) *	1994-10-18	1996-08-27	Clintec Nutrition Co.	Enternal composition for pediatric patients
US5589468A (en) *	1995-01-13	1996-12-31	Clintec Nutrition Co.	Method for providing nutrition to elderly patients
CA2141126A1 (en)	1995-01-26	1996-07-27	Natalie J. Lazarowych	Combinational drug for treating migraine and other illnesses
US5728678A (en) *	1995-06-06	1998-03-17	Nestec Ltd.	Method and composition for providing nutrition to a renal failure patient
ES2123903T5 (es) *	1995-08-04	2011-02-22	N.V. Nutricia	Composición nutritiva conteniendo fibra.
US5635199A (en) *	1995-10-27	1997-06-03	Nestec Ltd.	Support of pediatric patients
US5801159A (en) *	1996-02-23	1998-09-01	Galileo Laboratories, Inc.	Method and composition for inhibiting cellular irreversible changes due to stress
US6077828A (en)	1996-04-25	2000-06-20	Abbott Laboratories	Method for the prevention and treatment of cachexia and anorexia
US6221836B1 (en) *	1996-07-26	2001-04-24	Paxton King Beale	Composition of pyruvate and anabolic protein and method for increasing fat loss in a mammal
CZ39699A3 (cs) *	1996-08-09	1999-07-14	Mannatech, Inc.	Směsi rostlinných uhlohydrátů jako potravinových doplňků
FR2754181B1 (fr)	1996-10-03	1998-12-04	Oenobiol S A Lab	Nouvelles utilisations de compositions a base d'alpha-lactalbumine
GB9701675D0 (en) *	1997-01-28	1997-03-19	Bridgeman Keith	Composition for the treatment of parkinson's disease
US5922766A (en) *	1997-07-02	1999-07-13	Acosta; Phyllis J. B.	Palatable elemental medical food
EP0891719A1 (de)	1997-07-14	1999-01-20	N.V. Nutricia	Narungszusammensetzungen mit Gehalt an Methionin
WO1999029310A2 (en)	1997-12-05	1999-06-17	Medical College Of Georgia Research Institute, Inc.	Regulation of t cell-mediated immunity by tryptophan and its analogs
US5817695A (en) *	1997-12-24	1998-10-06	Pellico; Michael A.	Nutritional product with high fat, low carbohydrate and amino acid imbalance
US6048846A (en) *	1998-02-26	2000-04-11	Cochran; Timothy M.	Compositions used in human treatment
US6475539B1 (en) *	1998-05-07	2002-11-05	Abbott Laboratories	Nutritionally complete low pH enteral formula
EP0951842B1 (de) *	1999-01-20	2002-12-04	N.V. Nutricia	Säuglingsnährpräparat
US6420342B1 (en) *	2000-05-08	2002-07-16	N.V. Nutricia	Nutritional preparation comprising ribose and medical use thereof
US7226916B1 (en)	2000-05-08	2007-06-05	N.V. Nutricia	Preparation for the prevention and/or treatment of vascular disorders
US20020147153A1 (en) *	2001-02-14	2002-10-10	Functional Foods, Inc.	Nutritional supplement to alleviate symptoms associated with reduced levels of serotonin
US6660293B2 (en) *	2001-06-29	2003-12-09	Everett Laboratories, Inc.	Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects
US7867541B2 (en) *	2003-04-14	2011-01-11	Mead Johnson Nutrition Company	Compositions and methods of formulation for enteral formulas containing sialic acid
DK1800675T3 (da)	2005-12-23	2011-09-05	Nutricia Nv	Sammensætninger omfattende polyumættede fedtsyrer, proteiner og mangan og/eller molybdæn og nucleosider/nucleotider til behandling af demens

1999
- 1999-04-29 EP EP99201359A patent/EP0951842B1/de not_active Expired - Lifetime
- 1999-04-29 DE DE69904257T patent/DE69904257T2/de not_active Expired - Lifetime
- 1999-04-29 DK DK99201359T patent/DK0951842T3/da active
- 1999-04-29 ES ES99201359T patent/ES2187115T3/es not_active Expired - Lifetime
- 1999-04-29 AT AT99201359T patent/ATE228779T1/de active
- 1999-04-29 PT PT99201359T patent/PT951842E/pt unknown
2000
- 2000-01-20 EP EP00903030A patent/EP1143974B1/de not_active Revoked
- 2000-01-20 CA CA002359592A patent/CA2359592C/en not_active Expired - Lifetime
- 2000-01-20 DE DE60019722T patent/DE60019722T2/de not_active Expired - Lifetime
- 2000-01-20 JP JP2000594467A patent/JP2002535277A/ja active Pending
- 2000-01-20 CA CA2627837A patent/CA2627837C/en not_active Expired - Lifetime
- 2000-01-20 ES ES00903030T patent/ES2240060T3/es not_active Expired - Lifetime
- 2000-01-20 US US09/889,793 patent/US6900180B1/en not_active Expired - Lifetime
- 2000-01-20 WO PCT/NL2000/000043 patent/WO2000042868A1/en not_active Ceased
- 2000-01-20 WO PCT/NL2000/000042 patent/WO2000043013A1/en not_active Ceased
- 2000-01-20 AU AU24665/00A patent/AU2466500A/en not_active Abandoned
- 2000-01-20 AT AT00903030T patent/ATE293974T1/de active
- 2000-01-20 US US09/889,691 patent/US6613367B1/en not_active Expired - Lifetime
- 2000-01-20 AU AU24666/00A patent/AU2466600A/en not_active Abandoned
2005
- 2005-05-10 US US11/125,201 patent/US8124585B2/en not_active Expired - Fee Related
2007
- 2007-07-18 JP JP2007187280A patent/JP2007291135A/ja active Pending
2008
- 2008-02-19 US US12/033,379 patent/US8450347B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1143974B1 (de)	2005-04-27
JP2002535277A (ja)	2002-10-22
WO2000042868A1 (en)	2000-07-27
EP0951842B1 (de)	2002-12-04
DE69904257D1 (de)	2003-01-16
PT951842E (pt)	2003-04-30
WO2000043013A1 (en)	2000-07-27
DE69904257T2 (de)	2003-04-17
JP2007291135A (ja)	2007-11-08
US20080145451A1 (en)	2008-06-19
ATE228779T1 (de)	2002-12-15
CA2359592A1 (en)	2000-07-27
DE60019722D1 (de)	2005-06-02
US8450347B2 (en)	2013-05-28
AU2466600A (en)	2000-08-07
CA2359592C (en)	2008-07-29
CA2627837A1 (en)	2000-07-27
EP0951842A3 (de)	1999-12-22
ES2240060T3 (es)	2005-10-16
ES2187115T3 (es)	2003-05-16
EP0951842A2 (de)	1999-10-27
US8124585B2 (en)	2012-02-28
DK0951842T3 (da)	2003-01-06
EP1143974A1 (de)	2001-10-17
CA2627837C (en)	2013-09-10
DE60019722T2 (de)	2005-11-17
AU2466500A (en)	2000-08-07
US6613367B1 (en)	2003-09-02
US20050256031A1 (en)	2005-11-17
US6900180B1 (en)	2005-05-31

Legal Events

Date

Code

Title

Description

2005-10-15

UEP

Publication of translation of european patent specification

Ref document number: 1143974

Country of ref document: EP

Publication	Publication Date	Title
ATE293974T1 (de)	2005-05-15	Pharmazeutische zusammensetzungen zur unbehagenverminderung
PT1411960E (pt)	2006-08-31	Produto alimentar enriquecido a base de farelo de arroz para promocao da saude cardiovascular
CY1110353T1 (el)	2015-04-29	Ανοσορρυθμιστικοι ολιγοσακχαριτες
DE60229286D1 (de)	2008-11-20	Lebensmittel oder tierfutter enthaltend die knochengesundheit unterstützendes pflanzenextrakt aus amelanchier
IL180528A0 (en)	2007-06-03	Pharmaceutical formulations for treating mitochondrial disorders
IL225192A (en)	2017-12-31	Combinations of dextromethorphan and quinidine for the preparation of mental illness, neuropathic pain or brain injury
BR9712259A (pt)	2000-01-25	Colostrininin, uso do mesmo, processos de tratar distúrbios do sistema nervoso central e/ou do sistema imune, de preparar colostrinin de colostro de mamìferos e de produzir uma composição farmacêutica, composição farmacêutica, suplemento dietético, nanopeptìdeo, e, uso do mesmo.
NO20042151L (no)	2004-09-07	Sammensetning for a forbedre skjelettvekst og opprettholdelse av benhelse
Craenen et al.	2020	An appraisal of folates as key factors in cognition and ageing-related diseases
WO2003068231A3 (de)	2003-12-24	Mittel, enthaltend folsäure, vitamin b6 und vitamin b12, und dessen verwendung
TW200513197A (en)	2005-04-16	Amino acid supplementation for a healthy microbiota ecosystem
ATE458004T1 (de)	2010-03-15	Osteoprotegerin in milch
Ravančić et al.	2022	Supplements and Down Syndrome
Pallewad et al.	2019	Vitamin D deficiency: how prevalent it is?
PT1592311E (pt)	2010-08-11	Óleo alimentar enriquecido em vitaminas que favorecem a assimilação do cálcio
Bereznicki et al.	0	Vitamin supplemerlts in
Beighton et al.	1997	CANAVAN, Myrtelle M. 1879–1955
UA6404U (en)	2005-05-16	Method for stimulating mental abilities in children
UA31379A (uk)	2000-12-15	Спосіб лікування ішемічної хвороби серця